DNA-binding properties of poly(ADP-ribose) polymerase: a target for anticancer therapy
1Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057-1482, USA. soldates@georgetown.edu
Current Drug Targets
|May 12, 2004
Summary
Poly(ADP-ribose) polymerase-1 (PARP-1) acts as a DNA damage sensor, crucial for genome integrity. Its DNA-binding properties are key to developing cancer treatments that sensitize tumor cells to genotoxic therapies.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Poly(ADP-ribose) polymerization is a critical post-translational modification involving NAD+.
- Poly(ADP-ribose) polymerase-1 (PARP-1) is a zinc finger protein that binds to DNA strand breaks.
Purpose of the Study:
- To review the DNA-binding properties of PARP-1.
- To explore how these properties can be leveraged to sensitize tumor cells to genotoxic treatments.
Main Methods:
- Review of existing scientific literature on PARP-1 and its interactions with DNA.
- Analysis of PARP-1's role in DNA repair, replication, recombination, and gene expression.
- Examination of PARP-1's recognition of various DNA structural discontinuities.
Main Results:
- PARP-1 functions as an intracellular sensor for DNA strand breaks.
- PARP-1 is involved in DNA repair, replication, recombination, and gene expression regulation.
- PARP-1 binds to diverse DNA structures beyond simple strand breaks.
Conclusions:
- PARP-1 plays a vital role in maintaining genome integrity and responding to DNA damage.
- PARP-DNA interactions are essential for PARP-1 function.
- Understanding PARP-1's DNA-binding characteristics is crucial for developing novel cancer therapies.
Related Concept Videos
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
01:56Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:03Single-Strand DNA Binding Proteins
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...